Propofol
Who holds supplier records for Propofol? 11 organisations hold a current record for Propofol: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), China (2), Switzerland (1), Italy (1) and 2 other countries (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Propofol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/propofol
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Propofol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Bachem SA, Succursale de VionnazSwitzerlandCEP Company GMP cert on recordActive DMF 11204 · latest filing Nov 1994
- CURIA ITALY SRLItalyCEP Company GMP cert on recordActive DMF 10868 · latest filing Apr 1994
- Emcure Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 27390 · latest filing Aug 2013
- MIDAS PHARMA GMBHGermanyCEP Company GMP cert on recordActive DMF 41009 · latest filing May 2025
- Neuland Laboratories LimitedIndiaCEPActive DMF 27418 · latest filing Aug 2013
- SI GROUPUnited StatesCEPActive DMF 11777 · latest filing Dec 1995
- JILIN ASYMCHEM LABORATORIES CO LTDActive DMF 43466 · latest filing Apr 2026
- YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChinaActive DMF 41627 · latest filing Mar 2025
- ASolution Pharmaceuticals Pvt. Ltd.IndiaCEP
- HARMAN FINOCHEM LTDIndiaCEP Company GMP cert on recordInactive DMF 29006 · latest filing Feb 2015
- GUANGDONG JIABO PHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (9)
Certificates of Suitability on the EDQM register for Propofol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 15 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| EMCURE PHARMACEUTICALS LIMITED Pune | IN | CEP 2024-066 - Rev 01 Propofol, PFL | Nov 2026 | — |
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2013-202 - Rev 05 Propofol | Jun 2026 | — |
| ASOLUTION PHARMACEUTICALS PRIVATE LIMITED Thane | IN | CEP 2024-324 - Rev 00 Propofol | Jun 2026 | — |
| SI GROUP, INC. The Woodlands | US | CEP 2002-229 - Rev 05 Propofol | May 2025 | — |
| HARMAN FINOCHEM LIMITED Mumbai | IN | CEP 2015-347 - Rev 02 Propofol | Apr 2025 | — |
| BACHEM SA Vionnaz | CH | CEP 2005-003 - Rev 05 Propofol, Code number 4037808 | Sept 2024 | Inspected Oct 2025 Switzerland |
| GUANGDONG JIABO PHARMACEUTICAL CO., LTD. Qingyuan | CN | R0-CEP 2022-494 - Rev 00 Propofol | Aug 2023 | — |
| MIDAS PHARMA GMBH Ingelheim am Rhein | DE | R0-CEP 2021-363 - Rev 00 Propofol | Feb 2022 | — |
| CURIA ITALY S.R.L. Origgio | IT | R1-CEP 2001-267 - Rev 04 Propofol | Aug 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Propofol are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- India · Inactive DMF 23723 · filed Apr 2010
- Italy · Inactive DMF 15793 · filed Jan 2002
- ABBOTT LABORATORIES CHEMICAL AND AGRICULTURAL PRODUCTS DIVInactive DMF 11474 · filed Apr 1995
- PORTON FINE CHEMICALS LTDInactive DMF 11406 · filed Mar 1995
- ZENECA PHARMACEUTICALSInactive DMF 8915 · filed Jan 1991
Overview
Propofol is a short-acting intravenous anesthetic agent used for the induction and maintenance of general anesthesia. It provides rapid sedation and quick recovery with minimal side effects.
Chemical identity
- IUPAC name
- 2,6-di(propan-2-yl)phenol
- Canonical SMILES
- CC(C)C1=C(C(=CC=C1)C(C)C)O
- InChIKey
- OLBCVFGFOZPWHH-UHFFFAOYSA-N
- Synonyms
- Diprivan API, diprivan, fresofol, ici 35,868, ici 35-868, ici-35868, ici35,868, ketafol component propofol, lipuro, phenol, 2,6-bis(1-methylethyl)
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- General Anesthetic
- Physiologic effect
- General Anesthesia
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Propofol?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Propofol: Bachem SA, Succursale de Vionnaz (Switzerland), CURIA ITALY SRL (Italy), Emcure Pharmaceuticals Limited (India), MIDAS PHARMA GMBH (Germany), Neuland Laboratories Limited (India), SI GROUP (United States), JILIN ASYMCHEM LABORATORIES CO LTD and YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD (China), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Propofol Drug Master Files are active?
Bachem SA, Succursale de Vionnaz (DMF 11204), CURIA ITALY SRL (DMF 10868), Emcure Pharmaceuticals Limited (DMF 27390), MIDAS PHARMA GMBH (DMF 41009), Neuland Laboratories Limited (DMF 27418), SI GROUP (DMF 11777), JILIN ASYMCHEM LABORATORIES CO LTD (DMF 43466) and YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD (DMF 41627). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Propofol records mean?
5 organisations have only inactive Type II DMFs for Propofol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Propofol have a European Certificate of Suitability?
Yes. 9 organisations hold a valid CEP for Propofol on the EDQM register, including EMCURE PHARMACEUTICALS LIMITED Pune (IN), NEULAND LABORATORIES LIMITED Hyderabad (IN), ASOLUTION PHARMACEUTICALS PRIVATE LIMITED Thane (IN), SI GROUP, INC. The Woodlands (US), HARMAN FINOCHEM LIMITED Mumbai (IN) and BACHEM SA Vionnaz (CH) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Propofol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Propofol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.